KRYS vs. KLAC
Compare and contrast key facts about Krystal Biotech, Inc. (KRYS) and KLA Corporation (KLAC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KRYS or KLAC.
Correlation
The correlation between KRYS and KLAC is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
KRYS vs. KLAC - Performance Comparison
Loading data...
Key characteristics
KRYS:
-0.23
KLAC:
0.14
KRYS:
-0.09
KLAC:
0.54
KRYS:
0.99
KLAC:
1.07
KRYS:
-0.30
KLAC:
0.20
KRYS:
-0.68
KLAC:
0.37
KRYS:
17.14%
KLAC:
18.94%
KRYS:
43.91%
KLAC:
49.49%
KRYS:
-53.42%
KLAC:
-83.74%
KRYS:
-34.74%
KLAC:
-14.19%
Fundamentals
KRYS:
$3.82B
KLAC:
$92.73B
KRYS:
$4.17
KLAC:
$27.49
KRYS:
31.70
KLAC:
25.51
KRYS:
11.46
KLAC:
8.03
KRYS:
3.88
KLAC:
23.15
KRYS:
$333.45M
KLAC:
$11.55B
KRYS:
$308.79M
KLAC:
$7.03B
KRYS:
$92.22M
KLAC:
$4.88B
Returns By Period
In the year-to-date period, KRYS achieves a -11.00% return, which is significantly lower than KLAC's 20.96% return.
KRYS
-11.00%
-15.50%
-28.82%
-9.91%
19.83%
N/A
KLAC
20.96%
13.47%
14.75%
6.82%
37.73%
31.51%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
KRYS vs. KLAC — Risk-Adjusted Performance Rank
KRYS
KLAC
KRYS vs. KLAC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Krystal Biotech, Inc. (KRYS) and KLA Corporation (KLAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
KRYS vs. KLAC - Dividend Comparison
KRYS has not paid dividends to shareholders, while KLAC's dividend yield for the trailing twelve months is around 0.83%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KRYS Krystal Biotech, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KLAC KLA Corporation | 0.83% | 0.96% | 0.92% | 1.25% | 0.91% | 1.35% | 1.74% | 3.17% | 2.15% | 2.67% | 2.94% | 26.17% |
Drawdowns
KRYS vs. KLAC - Drawdown Comparison
The maximum KRYS drawdown since its inception was -53.42%, smaller than the maximum KLAC drawdown of -83.74%. Use the drawdown chart below to compare losses from any high point for KRYS and KLAC. For additional features, visit the drawdowns tool.
Loading data...
Volatility
KRYS vs. KLAC - Volatility Comparison
Krystal Biotech, Inc. (KRYS) has a higher volatility of 19.05% compared to KLA Corporation (KLAC) at 13.53%. This indicates that KRYS's price experiences larger fluctuations and is considered to be riskier than KLAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
KRYS vs. KLAC - Financials Comparison
This section allows you to compare key financial metrics between Krystal Biotech, Inc. and KLA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KRYS vs. KLAC - Profitability Comparison
KRYS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported a gross profit of 83.16M and revenue of 88.18M. Therefore, the gross margin over that period was 94.3%.
KLAC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, KLA Corporation reported a gross profit of 1.89B and revenue of 3.06B. Therefore, the gross margin over that period was 61.6%.
KRYS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported an operating income of 36.18M and revenue of 88.18M, resulting in an operating margin of 41.0%.
KLAC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, KLA Corporation reported an operating income of 1.30B and revenue of 3.06B, resulting in an operating margin of 42.5%.
KRYS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported a net income of 35.73M and revenue of 88.18M, resulting in a net margin of 40.5%.
KLAC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, KLA Corporation reported a net income of 1.09B and revenue of 3.06B, resulting in a net margin of 35.5%.